DNA RNA and Cells

17 Nov 2008 InteRNA Technologies and Cenix BioScience Ink Research Agreement for miRNA Drug Discovery
13 Nov 2008 ZaBeCor's Investigational New Drug Application Approved by the FDA
11 Nov 2008 Sangamo BioSciences Announces Results From Diabetic Neuropathy Clinical Trial SB-509-601
10 Nov 2008 Celgene Cellular Therapeutics Receives FDA Clearance for First Placenta-Derived Stem Cell Clinical Study
06 Nov 2008 Pervasis Therapeutics Presents Safety Data from Phase 1 and 2 Clinical Trials of Vascugel(R) at the American Society of Nephrology Annual Meeting
04 Nov 2008 Alnylam and Collaborators Publish Research on a New Class of Chemically Modified RNAi Therapeutics that Target Two Distinct Cellular Mechanisms
04 Nov 2008 Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
30 Oct 2008 StemCells, Inc. Announces Preclinical Results Showing its Proprietary Human Neural Stem Cells Can Prevent Vision Loss
29 Oct 2008 Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
28 Oct 2008 Geron Scientists and Collaborators Demonstrate Activity of Pancreatic Islet-like Cells Derived from Human Embryonic Stem Cells in Diabetes
27 Oct 2008 Ophthotech Enrolls First Patient in a Phase I Complement (Anti-C5) Inhibitor Trial for Macular Degeneration
23 Oct 2008 Novo Nordisk, Cellartis and Lund University enter into a collaboration to develop insulin-producing cells from stem cells for the treatment of diabetes
20 Oct 2008 Archemix Signs Aptamer Therapeutics Agreement with Lilly
20 Oct 2008 Enzon Presents New Data on Its LNA Programs
20 Oct 2008 Geron Initiates Clinical Trial of GRN163L in Combination With Bortezomib and Dexamethasone in Patients With Multiple Myeloma
15 Oct 2008 ATL1101 suppresses tumour growth in key mouse models of prostate cancer
15 Oct 2008 Geron's GRN163L Sensitizes Resistant Breast Cancer Cells to Trastuzumab in Preclinical Study
14 Oct 2008 Regado Biosciences Completes Patient Enrollment for Phase IIa Study of REG1 Anticoagulation System
14 Oct 2008 Athersys Announces Initial Patient Dosing of MultiStem(r) in Phase I Acute Myocardial Infarction Trial
14 Oct 2008 RXi Pharmaceuticals Obtains an Exclusive Worldwide License to Technology for the Oral Delivery of RNAi Therapeutics from the University of Massachuset
13 Oct 2008 OncoGenex Achieves Key Regulatory Milestone for Lead Product Candidate, OGX-011
13 Oct 2008 Quark Pharmaceuticals Announces Publication of Study on Use of siRNA against Proprietary Target for Inhibiting Tumor Growth and Sensitization of Cancer Cells to Chemotherapy
12 Oct 2008 First Heart Failure Patients Successfully Implanted with Angioblast Systems’ “Off-the-Shelf” Adult Stem Cells
10 Oct 2008 AVONTEC announces the results of a successful proof of concept within a phase 2a study with its drug candidate AVT-02 UE ointment after topical treatment in patients with mild-to-moderate psoriasis
08 Oct 2008 Moraga Announces Licensing Agreement with Pharmacells, Ltd

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2018 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up